Ramsay Health Care stock
Price history
+71.02% over the period1 year: from $31.25 (November 18, 2025) to $53.45 (November 18, 2026), +71.02%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 18, 2026 | $53.45 |
| October 30, 2026 | $55.60 |
| September 30, 2026 | $55.68 |
| August 31, 2026 | $51.28 |
| July 31, 2026 | $44.34 |
| June 30, 2026 | $43.98 |
| May 29, 2026 | $37.09 |
| April 30, 2026 | $38.98 |
| March 31, 2026 | $39.01 |
| February 27, 2026 | $43.07 |
| January 30, 2026 | $36.36 |
| December 31, 2025 | $34.36 |
| November 28, 2025 | $36.81 |
| November 18, 2025 | $31.25 |
At a glance
The company
Owns and operates hospitals across Australia, the UK, France and the Nordics, providing services in cardiology, oncology, orthopaedics and mental health
Latest results
Quarter to June 30, 2026 · EPS $0.70 (estimate $1.18)
TickerLandia's take on Ramsay Health Care
- Pricier than usual relative to earnings: P/E on the latest fiscal year 39 vs a median of 33 over its last 9 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 41 vs 29 (+42%) in a group of 11.
- Strong point: Market momentum (91/100 in its group). Weak point: Profitability (5/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−5.41% from the 52-week high
Analysts · 15 analysts
Average target$52.11−2.50% vs. price
Buy 3 · Hold 11 · Sell 1 · Hold
TickerLandia Fingerprint: Ramsay Health Care
Compared with similar companies: very low profitability, very strong momentum, and very low financial strength.
Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.
Priceaverage51
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 41.1 81 Forward P/E 30.6 81 EV/EBITDA 10.4 39 Price/book 2.65 32 Price/sales 0.67 24 Profitabilityvery low5
How much it earns on revenue and capital.
Metric Value Position in group ROA 3.2% 3 ROE 5.7% 8 Gross margin 12.3% 3 Operating margin 5.9% 3 Net margin 1.8% 8 Earnings stabilityhigh70
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.2% 82 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 58 Growthaverage41
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +7.61% 29 Revenue growth (year over year) +0.95% 13 Earnings growth (year over year) +32.91% 82 Financial strengthvery low17
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 1.81 8 Current ratio 0.91 34 Debt/equitycounts in reverse: lower means more financial strength 1.97 19 Net debt/EBITDAcounts in reverse: lower means more financial strength 5.75 8 Dividendhigh74
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 29 years 97 Payout ratio 67.0% 68 Dividend yield 1.7% 56 Market momentumvery strong91
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +22.21% 87 Relative strength (6 months) +37.89% 93 1-year return +71.02% 93 Distance from 200-day average +19.34% 93 Risklow29
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 19.0% 13 Volatility (60 days) 30.6% 35 Beta (1 year) 0.58 39
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Ramsay Health Care is pricier than in the past and pricier than similar companies
On the latest fiscal year's earnings (2026), Ramsay Health Care's P/E today is 39.4, above the median of its last 9 fiscal years (32.7; between 27.9 and 66.9 from 2017 to 2026). Ramsay Health Care's P/E (trailing 12 months): 41.1, +42% against the median of a group of 11 similar companies (28.9).
Compared with 11 similar companies
| Metric | Ramsay Health Care | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 41.1 | Middle | |
| Forward P/E | 30.6 | Middle | |
| Operating margin | 5.9% | Low | |
| ROE | 5.7% | Low | |
| Debt/equity | 1.97 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Ramsay Health Care. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$9.31B
Latest quarter · Q2 2026
Net income
$168.5M
Latest quarter · Q2 2026
Quarterly net margin
1.8%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $12.78B
- P/E
- 41.1
- EPS
- $1.36
- Volume
- 743.49K
- Daily trading
- €20.65M
- Dividend yield
- 1.70%
- Last ex-dividend on September 3, 2026
How Ramsay Health Care is changing
All resultsRevenue grew 7.7% a year on average over the last 5 years
Operating margin rose from 4.4% to 5.9%
Profits turn into cash: free cash flow equal to 156% of net income
Returns
Ramsay Health Care returns with dividends
$1,000 invested in Ramsay Health Care 5 years ago, on November 18, 2021, would be worth $861 today with dividends reinvested: −13.91% in total, −2.95% per year. On price alone it would be $789 (−21.11%).
| Period | Ramsay Health Care | S&P/ASX 200 | $1,000 becomes |
|---|---|---|---|
| 1 month | −2.83% | +0.42% | $972 |
| 6 months | +44.02% | +4.44% | $1,440 |
| Year to date | +55.54% | +1.94% | $1,555 |
| 1 year | +74.38% | +4.89% | $1,744 |
| 3 years | +11.70% | +25.85% | $1,117 |
| 5 years | −13.91% | +20.38% | $861 |
| 10 years | −8.89% | +65.75% | $911 |
Over the last 6 months it has done better than 77% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P/ASX 200: price only. Calculate your investment
The chart in detail
Ramsay Health Care: technical analysis
Ramsay Health Care shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 36.7% below its all-time closing high ($84.37, April 22, 2022).
- Trend
- No clear trend
- RSI (14 sessions)
- 37
- Between 30 and 70
- vs 200-session average
- +19.34%
Support and resistance
Price areas where Ramsay Health Care has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$55.87+4.54%3 touches, last on October 16, 2026
- Resistance$53.67+0.43%3 touches, last on October 20, 2026
- Last price$53.45
- Support$52.74−1.33%2 touches, last on September 15, 2026
- Support$45.49−14.88%2 touches, last on August 13, 2026
- Support$44.58−16.58%2 touches, last on June 29, 2026
Volatility and risk
Over the last year it has moved less than the S&P/ASX 200.
- Beta (1 year) vs S&P/ASX 200
- 0.58
- Volatility (60 sessions, annualised)
- 30.6%
- Largest fall in the last year
- −18.98%
In session, November 18, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Ramsay Health Care: seasonality
Average monthly price change over 30 years
Over the last 30 years, the strongest month for Ramsay Health Care has been November: +3.65% on average, positive in 17 years out of 29. The weakest has been June: −1.40% on average, positive in 11 years out of 29.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.77% | +1.39% | 16 of 29 |
| February | +3.30% | +3.41% | 20 of 29 |
| March | −0.62% | 0.00% | 14 of 29 |
| April | +1.46% | +0.61% | 16 of 29 |
| May | +1.48% | +1.52% | 16 of 29 |
| June | −1.40% | −1.36% | 11 of 29 |
| July | +1.54% | +0.75% | 16 of 29 |
| August | +1.57% | +2.23% | 18 of 29 |
| September | −0.79% | −1.17% | 13 of 29 |
| October | +1.04% | +0.78% | 17 of 30 |
| November | +3.65% | +2.09% | 17 of 29 |
| December | +2.56% | +2.04% | 18 of 29 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Ramsay Health Care and its competitors
Private hospitals are how most people know Ramsay Health Care Limited, and the group runs them in Australia, the UK, France and the Nordics. Its clinical offer spans cardiology, cancer care, joint and bone surgery and mental health, delivered alongside hospital-in-the-home programmes, telehealth, and clinics and pharmacy franchises. Patients include both private and self-insured people, along with those referred by the NHS and public patients receiving care in its facilities.
- Headquarters
- St Leonards, Australia
- Employees
- 91,400
- Founded
- 1964
- Chief executive
- Natalie Davis
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Ramsay Health CareRHC | $8.61B | 5.9% | 41.1 | +44.02% |
| Max Healthcare InstituteMAXHEALTH | $9.86B | 21.4% | 67.0 | −1.83% |
| Fortis HealthcareFORTIS | $6.26B | 18.1% | 56.3 | −16.28% |
| Aier Eye Hospital Group300015 | $12.53B | 21.8% | 34.3 | −10.89% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | $13.16B | 12.1% | 54.4 | +7.79% |
| Ensign GroupENSG | $10.59B | 8.6% | 28.9 | +4.70% |
Same industry or related industries, similar size. Compare Ramsay Health Care with its competitors · Full profile
